| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |